Key result
Structured cardiovascular screening requires evaluating ~221 pediatric competitive athletes to identify one high-risk condition.
Why the study?
Sudden cardiac death in young athletes often stems from undiagnosed structural or electrical abnormalities detectable through screening, prompting evaluation of cardiovascular abnormalities during preparticipation screening in Adjara, Georgia.
Does structured cardiovascular screening identify high-risk cardiovascular abnormalities in pediatric competitive athletes?
Does structured cardiovascular screening identify high-risk cardiovascular abnormalities in pediatric competitive athletes?
Structured cardiovascular screening in pediatric athletes identifies high-risk conditions in 0.45% of the cohort, requiring 221 screens to detect one high-risk abnormality.
Hypothesis-generating for structured screening in pediatric athletes; leaves open outcome impact and cost-effectiveness before adoption.
Background: Sudden cardiac death (SCD) in children and adolescents is a rare but catastrophic event with substantial public health impact. A significant proportion of exercise-related SCD cases are attributable to previously undiagnosed structural or electrical cardiac abnormalities that may be detectable through systematic screening. Objective: To determine the prevalence, clinical spectrum, and risk stratification profile of cardiovascular abnormalities identified during structured preparticipation screening of pediatric competitive athletes in Adjara, Georgia, and to evaluate implications for sports safety policy. Methods: A cross-sectional cohort study was conducted in 2025 including 442 competitive athletes aged 7–18 years recruited through organized sports institutions in Adjara, Georgia. All participants underwent standardized cardiovascular evaluation including medical history, physical examination, electrocardiography, and echocardiography. Detected abnormalities were categorized into risk groups for sudden cardiac death. Results: Cardiovascular abnormalities were identified in 13.1% of athletes, with high-risk conditions detected in 0.45% of the cohort. The number needed to screen to detect one high-risk condition was 221 athletes. Conclusion: Structured cardiovascular screening identifies clinically relevant abnormalities in pediatric athletes and provides essential evidence to inform context-sensitive public health policy and sports safety strategies.
No takes yet. Share an insight, caveat, or question.
MIRANDA SHERVASHIDZE (2026) studied this question. Structured cardiovascular screening of pediatric competitive athletes identified abnormalities in 13.1% of the cohort and high-risk conditions in 0.45%, with a number needed to screen of 221.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: